Phase II, Randomized, Double-Blind, Placebo-Controlled Study of K0709 in Patients with Early Parkinson's Disease
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: SUN PHARMA ADVANCE RESEARCH
- Phase: II
- Execution start: 31/01/2020
- End of execution: 30/06/2021
- PI: ADOLFO MINGUEZ CASTELLANOS